Al Ittihad Drug Store (IDS), one of the UAE’s biggest pharmaceutical distributors, has announced a 28 percent rise in total sales turnover in the first quarter of 2015 compared to the year-earlier period.
The company, which is the exclusive distributor for a wide range of pharmaceutical and consumer products in the UAE, said the increase compared to overall industry growth of 12 percent in the same period.
Apart from the increase in total sales turnover, IDS said its consumer division saw sales rise by 43 percent, partly as a result of the launch of new products.
The company said it has also surpassed its own quarterly records with more than 1.3 million units packed, shipped and delivered in the market.
IDS has partnered with two new principals, namely Fillerina, an innovative product in the anti-aging category, and Medcoll, a premium Collagen product, and also launched an innovative line extension for PIC Insulin Pen Needles, it said.
IDS was the first company to launch a 32G pen needle in 2007, and by using this expertise they have launched Insupen 33G which is the smallest pen needle in terms of diameter and length, it added.
Ahmad Tabari, Group CEO, said: “We are extremely pleased to announce the outstanding growth results for Q1 2015… We are in the process of signing up with more principals for the rest of the year and we look ahead to set a new benchmark in the annual growth this year.”
IDS was established in 1968 and has a comprehensive distribution network supplying pharmacies, hospitals, clinics, supermarkets, self-service kiosks and petrol stations with products ranging from antibiotics to thermometers.
Follow us on
